SMAD2 and osteoporosis: CUR promotes osteoblast differentiation and matrix mineralization by enhancing the activity of the Transforming Growth Factor Beta (TGF-β)/Smad Family Member 2/3 (Smad2/3) signaling pathway, thereby improving the disordered trabecular bone structure caused by osteoporosis (40).